跳至主要内容
临床试验/NCT03801616
NCT03801616终止不适用

VR 4 BR: Effects of Virtual Reality on Women Undergoing Mastectomy and Breast Reconstruction, A Pilot Study

Cedars-Sinai Medical Center2 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2019年1月30日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
45
试验地点
2
主要终点
Morphine Milligram Equivalents

研究概览

简要总结

This is a pilot study of virtual reality (VR) non-opioid management for women undergoing mastectomy and implant-based reconstruction. Study participants will receive specialized VR interventions, administered via VR headsets, to manage pain.

详细描述

The primary objective of this study is to estimate the effect of utilizing VR on reducing opioid use in study participants undergoing mastectomy with implant-based reconstruction compared to the control group. Investigators will follow patients throughout the course of their hospitalization and monitor outcomes including pain levels, medication requests, and satisfaction.

Eligible participants will receive a VR headset and instructed to use the VR every time they feel pain and before asking for a pain medication. They can take pain medications, if they choose to do so. At their post-op visit, study participants will be interviewed and asked questions regarding their experience with VR.

Pain level and medication use will be compared with similar individuals who undergo the same procedure but are not provided with a VR headset.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Women who plan to undergo mastectomy and implant-based reconstruction
  • Written informed consent obtained from subject and ability for subject to comply with the requirements of the study.
  • Able to read and comprehend English

排除标准

  • Current diagnosis of epilepsy, dementia, or other neurologic disease that may prevent use of VR headset and software
  • Sensitivity to flashing light
  • Diagnosis of motion sickness
  • Pregnancy or a medical condition where the study participant is prone to frequent nausea or dizziness
  • Current or recent (less than 6 months) use of opioids
  • Individuals with psychiatric disorders, including those with delirium or other disorders that may involve hallucinations or psychosis

结局指标

主要结局

Morphine Milligram Equivalents

时间窗: During hospitalization until discharge, approximately 2 days

Opioid usage is defined as mean total milligrams of morphine equivalent (MME), calculated by first multiplying the quantity of each prescribed medication by the strength of that medication (milligrams of given opioid per unit dispensed), and then multiplying this quantity-strength product by conversion factors derived from published sources to estimate the milligrams of morphine equivalent to the opioids dispensed in the prescription.

次要结局

  • Mean Difference in Pain(From operation to discharge, approximately 2 days)
  • Mean Difference in Length of Stay(During hospitalization until discharge, approximately 2 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alice Chung

Assistant Professor of Surgery

Cedars-Sinai Medical Center

研究点 (2)

Loading locations...

相似试验